No products in the cart.
Solid tumors contain abnormal and heterotypic cells that communicate through tight and gap junctions. In [...]
All Antibodies Approved or in Clinical Trials ichorbio has created an editable spreadsheet that we [...]
Non-small cell lung cancer (NSCLC) is the most common lung cancer. There are three main [...]
Psoriasis is a skin disease that causes red, itchy scaly patches, most commonly on the [...]
ichorbio has created a document on how to write a great life science paper which [...]
ichorbio is pleased to release our new and updated flyer for all of our different [...]
ichorbio released a research grade (RUO) version of the biosimilar Durvalumab on 18th November 2021. [...]
ichorbio has released five new biosimilars targeting PD-1 and PD-L1. The biosimilars are as follows: [...]
Today, ichorbio is excited to announce the release of our second mouse anti-mouse recombinant antibody. [...]
Today, ichorbio is excited to announce the release of our first mouse anti-mouse recombinant antibody. [...]
ichorbio has released two new recombinant antibodies this month which are mouse anti-mouse versions of [...]
ichorbio has produced a flyer to showcase all of our biosimilars for research use only [...]
ichorbio has released 8 new products for August 2021, four bulk anti-human antibodies and six [...]
With the help of our partner, Binaree – ichorbio has been creating new immunofluorescence validation [...]
ichorbio has created a free to download PDF on ways to inject mice – click [...]
Username or email address *
Lost your password?
Email address *
A link to set a new password will be sent to your email address.
Sign me up for the newsletter!